We excluded patients with cirrhotic liver, history of gall bladder, biliary disorders, pancreatic diseases, interrupted use of GLP-1RAs throughout the study period, and patients used other drugs with potential effects on the motility of biliary tracts such as cholecystokinin, motilin hormone, cholinomimetic agents like prostigmine, erythromycin, cisapride, cholystyramine, intravenous aminoacids, cholinergic agents like atropine, somatostatin, and progesterone, trimebutine, loperamide and ondansetron
doi:10.1016/0304-3835(80)90122-6.[Crossref], [PubMed], [Web of Science ] , [Google Scholar])
By tailoring the dosage and formulation to the patient, its possible to minimize unwanted effects while maximizing therapeutic benefits
Seizure 21 , 194197 (2012)
Watch for: Persistent fatigue or feeling hangry can indicate you are eating too little
September 1720, 2019